gepirone

05/01/2004 - "Sustained efficacy of gepirone-IR in major depressive disorder: a double-blind placebo substitution trial."
03/01/2003 - "Gepirone-ER is effective for the short-term treatment of major depressive disorder and is well tolerated."
05/01/2011 - "To study the effect of gepirone-ER on HSDD in women with major depressive disorder (MDD). "
04/01/2008 - "Gepirone extended-release in the treatment of adult outpatients with major depressive disorder: a double-blind, randomized, placebo-controlled, parallel-group study."
04/01/2008 - "To evaluate the efficacy and tolerability of extended-release gepirone (gepirone-ER), a 5-HT(1A) agonist, versus placebo in the treatment of adult outpatients with major depressive disorder (MDD). "

04/01/1993 - "This preliminary study suggests the possible efficacy of gepirone in panic disorder."
04/01/1993 - "Gepirone and the treatment of panic disorder: an open study."

09/01/2011 - "Gepirone-extended release (ER) is effective in treating hypoactive sexual desire disorder (HSDD), as measured by the percent of females with HSDD that no longer met criteria for HSDD treatment. "
10/01/2011 - "Errata by Fabre et al. in gepirone-ER treatment of hypoactive sexual desire disorder associated with depression in women."
05/01/2011 - "Gepirone-ER treatment of hypoactive sexual desire disorder (HSDD) associated with depression in women."

09/01/1998 - "The test procedure resulted in "stress hyperthermia," which was reduced by Gepirone and increased by WAY. "
09/01/1995 - "The hyperthermia, measured via telemetry, in the "anticipatory" phase prior to defeat and in reaction to threats, was decreased by alcohol, gepirone and diazepam; alcohol and gepirone were also effective in attenuating "anticipatory" tachycardia. "
09/01/1995 - "The anxiolytic-like profile of hyperthermia, tachycardia, USV and defensive behavior in the "anticipatory" phase of the confrontation by alcohol, gepirone and diazepam contrasted with the lack thereof during the more intense reactive phase. "
03/01/1999 - "The purpose of the investigation was to ascertain whether (a) the antiaggressive effects of the 5-HT1A partial agonist, Gepirone, could be mediated via its anxiolytic action; (b) the selective 5-HT1A antagonist, WAY 100635, reversed these effects, and (c) the modulation of "stress hyperthermia" could be attributed to direct effects of the drugs. "

01/01/2020 - "No treatments are well proven, although cognitive behavior therapy, mindfulness meditation training, and serotonergic anxiolytics (buspirone, trazodone, gepirone) have potential, and phosphodiesterase type 5 inhibitors are effective for psychogenic ED and premature ejaculation. "